Videos

Slower aperiodic activity on magnetoencephalopathy may be associated with higher post-concussion symptomatology in high-school football players, according to new research to be presented at the Radiological Society of North America (RSNA) conference.

In a recent interview, Richard Duszak, MD, discussed new study findings that showed over nine percent annual increases in ultrasound, CT and MRI interpretation by office-based non-physician practitioners (NPPs) between 2013 and 2022.

In an interview, SNMMI president Cathy Cutler, PhD, discussed the impact of the recent CMS decision to unbundle reimbursement for diagnostic radiopharmaceuticals costing above $630 a day, calling it a “game changer” decision that will benefit patients, physicians, and the development of new radiopharmaceutical agents.

In a recent interview, Stamatia Destounis, M.D., discussed the impact of national breast density notification for mammography reports and key considerations with staffing and ongoing education for patients, staff and referring providers on the merits of supplemental breast imaging.

Key opinion leaders offer insights on closing knowledge gaps and highlight crucial factors for physicians to consider when interpreting gallium-based PET imaging results in clinical practice.

Medical experts address challenges and propose solutions for inter-readability concerns in nuclear medicine, particularly focusing on strategies to overcome the scarcity of specialized readers.

In a recent interview, Bridget Koontz, M.D., discussed the capability of the PET imaging agent 18F-flotufolastat for diagnosing post-prostatectomy recurrence of prostate cancer in patients with PSA values less than 1 ng/mL, based on research presented at the American Society for Radiation Oncology (ASTRO) conference.

Key opinion leaders explore the significance of interdisciplinary collaboration in prostate cancer management, with a focus on how PSMA PET imaging enhances decision-making processes within multidisciplinary care teams.

Jaideep Sohi, MD, and Jeremie Calais, MD, conduct a comparative assessment of gallium-based and non-gallium-based imaging agents for their efficacy in detecting and characterizing oligometastatic prostate cancer.

Medical experts conduct a comparative assessment of gallium-based and non-gallium-based imaging agents to determine their efficacy in detecting and characterizing oligometastatic prostate cancer.

Jaideep Sohi, MD, and Jeremie Calais, MD, explore the complexities of managing oligometastatic disease, emphasizing the critical role of accurately assessing lesion counts, metastatic spread, and disease thresholds in optimizing clinical outcomes.

Key opinion leaders examine the role of advanced imaging agents, particularly PSMA PET and other radiotracers, in identifying and defining oligometastatic disease in patients with prostate cancer.

Experts in radiology imaging evaluate the impact and efficacy of PSMA PET in improving early detection methods and refining prostate cancer staging processes.

Key opinion leaders analyze the advantages of integrating PSMA PET imaging with traditional imaging techniques to enhance prostate cancer management and treatment strategies.

Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.

In a recent interview, Soroush Rais-Bahrami, M.D., discussed key findings from a post-hoc subgroup analysis of the SPOTLIGHT trial that examined the use of the PET imaging agent 18F-flotufolastat (Posluma) in African American men.

In a recent interview at the SNMMI conference, David Gauden, D.Phil, discussed key findings from new research evaluating the use of the PET radiotracer 18F-flotufolastat in patients with primary prostate cancer (PCa) and men with biochemical recurrence of PCa.

In an interview at the SNMMI 2024 conference, Oliver Sartor, M.D. discussed key findings from new award-winning research evaluating the potential of Pluvicto in treating patients with taxane-naïve metastatic castration-resistant prostate cancer (mCRPC).

In a recent interview, Cathy Cutler, Ph.D., shared her perspective on a number of topics affecting nuclear medicine, ranging from isotope availability and reimbursement challenges for diagnostic radiopharmaceuticals to increasing patient interest in PET imaging.

In a recent interview, Stacy Smith-Foley, M.D., shared her perspective on the shortcomings of the recently issued breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).

In a recent interview, Steven Raman, M.D., discussed the use of MRI-guided transurethral ultrasound (TULSA) in the treatment of intermediate risk prostate cancer and key research findings with one- and five-year outcomes.

Discussing findings from a new study presented at the Society for Breast Imaging (SBI) conference, Shahrzad Tavana, M.D., detailed the significant impact of training sessions for MRI technologists in improving breast positioning, optimal field of view and accuracy of sequence submissions to PACS for breast MRI exams.

In a recent interview, Atul Gupta, M.D. discussed the evolution and potential impact of Fiber Optic RealShape (FORS) technology, which uses light instead of radiation to facilitate real-time 3D imaging that may lead to significant efficiencies with complex aortic procedures.

In a recent interview, Markus Scherer, M.D., discussed emerging research, presented at the American College of Cardiology Cardiovascular Summit, which showed that coronary computed tomography angiography (CTA) was associated with a significantly higher likelihood of revascularization in comparison to other modalities or direct referral for invasive coronary angiography.

In a recent interview, Eric Secemsky, M.D., discussed an array of benefits for the use of intravascular ultrasound (IVUS) in supplementing angiography for peripheral vascular interventions, current barriers preventing more widespread adoption of the technology and other salient insights from a recent multidisciplinary roundtable discussion.

In a recent interview, Alexander Rau, M.D., discussed emerging research, presented at the recent RSNA conference, that shows the capability of diffusion microstructural imaging to differentiate subtle shifts in microstructural gray matter associated with common symptomatology of long Covid.

In an interview at the recent RSNA conference, Catherine Everett, M.D., shared her perspective on the radiology workforce shortage, offered insights on recruiting radiologists to rural areas and emphasized the urgency of bolstering access to radiologists and other health-care professionals for at-risk communities.

In a recent interview, Mahsa Dolatshahi, M.D., M.P.H., and Cyrus A. Raji, M.D., Ph.D., discussed MRI and PET study findings, presented at the Radiological Society of North America (RSNA) conference, that showed an association between higher amyloid PET tracer uptake in the precuneus cortex and a higher visceral to subcutaneous fat ratio.

In a recent interview at the annual RSNA conference in Chicago, Richard Heller, MD discussed the impact of reduced reimbursement rates in radiology, the projected CMS conversion factor for 2024, the severity of payment cuts in interventional radiology and the importance of radiologist advocacy.

Dr. Kottler sat down with Diagnostic Imaging at RSNA 2023 to discuss AI imaging milestones and the potential impact of AI on workflows in radiology.